Free Trial

Lexaria Bioscience (LEXX) Earnings Date, Estimates & Call Transcripts

$3.14
+0.12 (+3.97%)
(As of 07/24/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

LEXX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LEXX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lexaria Bioscience Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20242($0.13)($0.05)($0.09)
Q4 20242($0.12)($0.05)($0.09)
20244($0.25)($0.10)($0.18)
Q1 20251($0.07)($0.07)($0.07)
Q2 20251($0.07)($0.07)($0.07)
Q3 20251($0.07)($0.07)($0.07)
Q4 20251($0.06)($0.06)($0.06)
FY 20254($0.27)($0.27)($0.27)

LEXX Earnings Date and Information

Lexaria Bioscience has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 19th, 2024 based off prior year's report dates.

Lexaria Bioscience Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/19/2024
(Estimated)
------- 
4/9/2024Q2 2024-($0.06)($0.06)($0.06)-$0.15 million
1/12/2024Q1 2024-($0.13)($0.13)($0.13)-$0.15 million
11/21/2023Q4 2023($0.17)($0.12)+$0.05($0.12)--
7/14/2023Q3 2023($0.25)($0.37)($0.12)($0.37)$0.08 million$0.09 million
4/14/2023Q2 2023-($0.22)($0.22)($0.22)-$0.04 million
1/17/2023Q1 2023-($0.30)($0.30)($0.30)-$0.10 million
11/25/2022Q4 2022-($0.24)($0.24)($0.24)-$0.11 million
7/14/2022Q3 2022($0.28)($0.41)($0.13)($0.41)$0.12 million$0.10 million
4/11/2022Q2 2022($0.21)($0.25)($0.04)($0.25)$0.15 million$0.03 million
1/14/2022Q1 2022-($0.35)($0.35)($0.35)-$0.01 million
7/15/2021Q3 2021-($0.40)($0.40)($0.30)-$0.20 million
4/14/2021Q2 2021-($0.28)($0.28)($0.65)-$0.19 million
1/14/2021Q1 2021-($0.24)($0.24)($0.24)-$0.30 million
10/14/2020Q4 2020-($0.30)($0.30)($0.30)-$0.13 million

Lexaria Bioscience Earnings - Frequently Asked Questions

When is Lexaria Bioscience's earnings date?

Lexaria Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 19th, 2024 based off last year's report dates. Learn more on LEXX's earnings history.

How much revenue does Lexaria Bioscience generate each year?

Lexaria Bioscience (NASDAQ:LEXX) has a recorded annual revenue of $230,000.00.

How much profit does Lexaria Bioscience generate each year?

Lexaria Bioscience (NASDAQ:LEXX) has a recorded net income of -$6.66 million. LEXX has generated -$0.44 earnings per share over the last four quarters.

What is Lexaria Bioscience's EPS forecast for next year?

Lexaria Bioscience's earnings are expected to grow from ($0.43) per share to ($0.37) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:LEXX) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners